Thrombocytopenia induced by imatinib mesylate (Glivec) in patients with chronic myelogenous leukemia: Is 400 mg daily of imatinib mesylate an optimal starting dose for Japanese patients? [2]

International Journal of Hematology

Volumn 77, Issue 1, 2003, Pages 93-95

  Miyazawa, Keisuke ^a   Nishimaki, Jiroh ^a   Katagiri, Tomoko ^a   Sashida, Goro ^a   Shoji, Nahoko ^a   Kawakubo, Ken ^a   Suzuki, Akitaka ^a   Shimamoto, Takashi ^a   Gotoh, Akihiko ^a   Kuriyama, Yuzuru ^a   Ito, Yoshikazu ^a   Tauchi, Tetsuzo ^a   Kawanishi, Yoshikazu ^b   Kimura, Yukihiko ^a   Ohyashiki, Kazuma ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; HYDROXYUREA; IMATINIB; INTERFERON; RANIMUSTINE; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ABDOMINAL PAIN; ADULT; AGED; ANEMIA; BONE MARROW CELL; CANCER PATIENT; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DIARRHEA; DOSE RESPONSE; EDEMA; FATIGUE; FEMALE; FEVER; HEADACHE; HUMAN; JAPAN; LETTER; LEUKOPENIA; LIVER DISEASE; MALE; NAUSEA; NEUTROPENIA; PHILADELPHIA 1 CHROMOSOME; RASH; RISK BENEFIT ANALYSIS; THROMBOCYTOPENIA; VERTIGO; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; JAPAN; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; PIPERAZINES; PYRIMIDINES; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 0038312198     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982610     Document Type: Letter

References (3)

1. Peng B, Hayes M, Druker B, et al. Clinical pharmacokinetics and pharmakodynamics of ST1571 in a phase I trial in CML patients. AACR Proc. 2000;41:256a.
2. Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med. 2001;344:1031-1037.
3. Kantarjian H, Sawyers C, Hochhaus A, et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med. 2002;346:645-652.